Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
复制标题

DOI:
10.1084/jem.20220131
复制
发表时间:
2022-08-01
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

在一个由112名因中度至危重COVID-19肺炎住院的儿童组成的国际队列中,我们发现12名儿童患有四种已知的I型干扰素免疫隐性先天性缺陷之一:X连锁TLR 7和常染色体IFNAR 1,STAT 2和TYK 2缺陷。I型干扰素(IFN)免疫的隐性或显性先天性缺陷可能是未接种疫苗的成人严重COVID-19肺炎的基础。未接种疫苗的儿童患COVID-19肺炎的风险远低于未接种疫苗的成年人,这一点仍然无法解释。在一个由112名儿童组成的国际队列中,(<16岁)因COVID-19肺炎住院,我们报告了12名儿童(10.7%)年龄1.5-13岁,(7名儿童)、重度(3名)和中度(2名)肺炎,以及15例已知的临床隐性和生化完全先天性I型IFN免疫缺陷中的4例:X连锁隐性TLR 7缺陷(7例儿童)和常染色体隐性IFNAR 1(1例)、STAT 2(1例)或TYK 2(3例)缺陷。缺乏IFNAR 1、STAT 2或TYK 2的成纤维细胞对SARS-CoV-2非常脆弱。在1,224例无肺炎的SARS-CoV-2良性感染儿童和成人(P = 1.2 × 10−11)中,没有发现这15种缺陷,这些缺陷具有重叠的年龄、性别、血缘和种族特征。I型IFN免疫的隐性完全缺陷可能是10%的儿童COVID-19肺炎住院的原因。
In an international cohort of 112 children hospitalized for moderate to critical COVID-19 pneumonia, we identified 12 children with one of four known recessive inborn errors of type I interferon immunity: X-linked TLR7 and autosomal IFNAR1, STAT2, and TYK2 deficiencies. Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5–13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10−11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children.
DOI: 10.1126/science.abj7965
发表时间: 2021-11-26
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Casanova JL;Abel L
通讯作者: Abel L
危及生命的Covid-19患者中针对I型IFN的自身抗体。
DOI: 10.1126/science.abd4585
发表时间: 2020-10-23
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Bastard P;Rosen LB;Zhang Q;Michailidis E;Hoffmann HH;Zhang Y;Dorgham K;Philippot Q;Rosain J;Béziat V;Manry J;Shaw E;Haljasmägi L;Peterson P;Lorenzo L;Bizien L;Trouillet-Assant S;Dobbs K;de Jesus AA;Belot A;Kallaste A;Catherinot E;Tandjaoui-Lambiotte Y;Le Pen J;Kerner G;Bigio B;Seeleuthner Y;Yang R;Bolze A;Spaan AN;Delmonte OM;Abers MS;Aiuti A;Casari G;Lampasona V;Piemonti L;Ciceri F;Bilguvar K;Lifton RP;Vasse M;Smadja DM;Migaud M;Hadjadj J;Terrier B;Duffy D;Quintana-Murci L;van de Beek D;Roussel L;Vinh DC;Tangye SG;Haerynck F;Dalmau D;Martinez-Picado J;Brodin P;Nussenzweig MC;Boisson-Dupuis S;Rodríguez-Gallego C;Vogt G;Mogensen TH;Oler AJ;Gu J;Burbelo PD;Cohen JI;Biondi A;Bettini LR;D'Angio M;Bonfanti P;Rossignol P;Mayaux J;Rieux-Laucat F;Husebye ES;Fusco F;Ursini MV;Imberti L;Sottini A;Paghera S;Quiros-Roldan E;Rossi C;Castagnoli R;Montagna D;Licari A;Marseglia GL;Duval X;Ghosn J;HGID Lab;NIAID-USUHS Immune Response to COVID Group;COVID Clinicians;COVID-STORM Clinicians;Imagine COVID Group;French COVID Cohort Study Group;Milieu Intérieur Consortium;CoV-Contact Cohort;Amsterdam UMC Covid-19 Biobank;COVID Human Genetic Effort;Tsang JS;Goldbach-Mansky R;Kisand K;Lionakis MS;Puel A;Zhang SY;Holland SM;Gorochov G;Jouanguy E;Rice CM;Cobat A;Notarangelo LD;Abel L;Su HC;Casanova JL
通讯作者: Casanova JL
DOI: 10.1084/jem.20220028
发表时间: 2022-06-06
期刊: The Journal of experimental medicine
影响因子: --
作者:
通讯作者: --
DOI: 10.1038/35099560
发表时间: 2001-10-18
期刊: NATURE
影响因子: 64.8
作者:
Alexopoulou, L;Holt, AC;Flavell, RA
通讯作者: Flavell, RA
DOI: 10.1038/s41591-020-01202-8
发表时间: 2021-01-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Brodin, Petter
通讯作者: Brodin, Petter